Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist - Eisenberg, P; Figueroa-Vadillo, J; Zamora, R; Charu, V; Hajdenberg, J; Cartmell, A; Macciocchi, A; Grunberg, S (Cancer, 2003)